Successes and challenges of PARP inhibitors in cancer therapy

Tiffany K. Ricks; Haw Jyh Chiu; Gwynn Ison; Geoffrey Kim; Amy E. McKee; Paul Kluetz; Richard Pazdur

ArticleOPEN ACCESS

Successes and challenges of PARP inhibitors in cancer therapy

Ricks T
Chiu H
Ison G
et al.

Frontiers in Oncology

DOI: 10.3389/fonc.2015.00222

59Citations

69Readers

Author supplied keywords

BRCA1
BRCA2
Cancer
Drug resistance
Homologous recombination
PARP inhibitor

Cite

CITATION STYLE

APA

Ricks, T. K., Chiu, H. J., Ison, G., Kim, G., McKee, A. E., Kluetz, P., & Pazdur, R. (2015). Successes and challenges of PARP inhibitors in cancer therapy. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2015.00222

Successes and challenges of PARP inhibitors in cancer therapy

Author supplied keywords

Cite

Register to see more suggestions